Drugs / IDP-124
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03058783 | Aug 2018 → May 2020 | atopic eczema | Bausch Health Americas, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT03002571 | Jul 2018 → Apr 2020 | atopic eczema | Bausch Health Americas, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IDP-124 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03002571 ↗ |
| Route | Topical | “IDP-124 Lotion, twice-daily application” NCT03002571 ↗ |